# Alendronate

## Binosto effervescent 70mg

##### 

| 藥品代碼   | OBIN                                                                                                                                                                                                                                                                  |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | No Data                                                                                                                                                                                                                                                               |
| 用法用量   | 1 tablet once weekly.                                                                                                                                                                                                                                                 |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                          |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                            |
| 禁忌       | ■ Abnormalities of the esophagus which delay emptying such as stricture or achalasia ■ Inability to stand/sit upright for at least 30 minutes ■ Increased risk of aspiration ■ Hypocalcemia ■ Hypersensitivity to any component of this product                       |
| 副作用     | - **Common** - Gastrointestinal: Abdominal pain (2.1% to 6.6% )， Constipation (0.3% to 3.1% )， Diarrhea (0.6% to 3.1% )， Flatulence (2.6% to 4.1% )， Indigestion (1.7% to 3.6% )， Vomiting (pediatric patients， 29.4% ) - Neurologic: Headache (2.6% ) - Other: |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                   |

